THE EFFICACY OF FOURTEEN-DAYS ESOMEPRAZOLE AND AMOXICILLIN CONTAINING HIGH DOSE DUAL THERAPY IN THE TREATMENT OF FIRST-LINE ANTI-H. PYLORI THERAPY: A PROSPECTIVE RANDOMIZED TRIAL

被引：0
|
作者：
Huang, Pao-Yuan
Ma, Te-Ling
Tai, Wei-Chen
Liang, Chih-Ming
Wu, Keng-Liang
Chuah, Seng-Kee
机构：
来源：
GASTROENTEROLOGY | 2019年 / 156卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
436
引用
收藏
页码：S89 / S89
页数：1
相关论文
共 50 条
  • [1] A 14 day esomeprazole- and amoxicillin-containing high-dose dual therapy regimen achieves a high eradication rate as first-line anti-Helicobacter pylori treatment in Taiwan: a prospective randomized trial
    Tai, Wei-Chen
    Liang, Chih-Ming
    Kuo, Chung-Mou
    Huang, Pao-Yuan
    Wu, Cheng-Kun
    Yang, Shih-Cheng
    Kuo, Yuan-Hung
    Lin, Ming-Tsung
    Lee, Chen-Hsiang
    Hsu, Chien-Ning
    Wu, Keng-Liang
    Hu, Tsung-Hui
    Chuah, Seng-Kee
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2019, 74 (06) : 1718 - 1724
  • [2] Non-Bismuth Quadruple Therapy, Sequential Therapy or High-Dose Esomeprazole and Amoxicillin Dual Therapy for First-Line Helicobacter pylori Eradication: A Prospective Randomized Study
    Meriem, Zeriouh
    Elmekkaoui, Amine
    Bouqfar, Mouna
    Zazour, Abdelkrim
    Khannoussi, Wafaa
    Kharrasse, Ghizlane
    Abda, Naima
    Ismaili, Zahi
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (12)
  • [3] Efficacy and safety of high-dose esomeprazole–amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial
    Bi Hanxin
    Chen Xingxing
    Chen Yuxin
    Zhao Xin
    Wang Shasha
    Wang Jiehong
    Lyu Ting
    Han Shuang
    Lin Tao
    Li Mingquan
    Yuan Donghong
    Liu Junye
    Shi Yongquan
    中华医学杂志英文版, 2022, 135 (14) : 1707 - 1715
  • [4] Efficacy and safety of high-dose esomeprazole-amoxicillin dual therapy for Helicobacter pylori rescue treatment: a multicenter, prospective, randomized, controlled trial
    Bi, Hanxin
    Chen, Xingxing
    Chen, Yuxin
    Zhao, Xin
    Wang, Shasha
    Wang, Jiehong
    Lyu, Ting
    Han, Shuang
    Lin, Tao
    Li, Mingquan
    Yuan, Donghong
    Liu, Junye
    Shi, Yongquan
    CHINESE MEDICAL JOURNAL, 2022, 135 (14) : 1707 - 1715
  • [5] High-dose PPI-amoxicillin dual therapy with or without bismuth for first-line Helicobacter pylori therapy: A randomized trial
    Yu, Lou
    Luo, Laisheng
    Long, Xiaohua
    Liang, Xiao
    Ji, Yingjie
    Graham, David Y.
    Lu, Hong
    HELICOBACTER, 2019, 24 (04)
  • [6] High-dose esomeprazole and amoxicillin dual therapy for first-line Helicobacter pylori eradication: a proof of concept study
    Zullo, Angelo
    Ridola, Lorenzo
    De Francesco, Vincenzo
    Gatta, Luigi
    Hassan, Cesare
    Alvaro, Domenico
    Bellesia, Annamaria
    de Nucci, Germana
    Manes, Gianpiero
    ANNALS OF GASTROENTEROLOGY, 2015, 28 (04): : 448 - 451
  • [7] Vonoprazan and amoxicillin dual therapy for 14 days as the first-line treatment of Helicobacter pylori infection: A non-inferiority, randomized clinical trial
    Hu, Yi
    Huang, Xiang-Hua
    Zhou, Bo
    Liu, Meng-Lan
    Liu, Ye-Fei
    Yu, Tao
    Sun, Ping
    Tan, Bin-Bin
    Hu, Yang
    Cheng, Fei
    Pan, Xiao-Lin
    Hong, Jun-Bo
    Shu, Xu
    Zhu, Yin
    Lu, Nong-Hua
    HELICOBACTER, 2024, 29 (01)
  • [8] Ten-day vonoprazan-amoxicillin dual therapy versus 14-day esomeprazole-amoxicillin dual therapy for first-line Helicobacter pylori eradication: a prospective multicenter randomized controlled trial
    Zhou, Ben-Gang
    Guo, Ming-Wen
    Zhang, Li-Juan
    Liu, Zhi-Dong
    Liu, Chun-Hua
    Li, Xue-Feng
    Li, Shun-Song
    Xiao, Peng
    Bao, Bing
    Ai, Yao-Wei
    Ding, Yan-Bing
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2024, 17
  • [9] Efficacy and safety of vonoprazan-amoxicillin dual therapy for Helicobacter pylori first-line treatment: a single-center, randomized, controlled trial
    Wang, Xiaolei
    Teng, Guigen
    Dong, Xinhong
    Dai, Yun
    Wang, Weihong
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2023, 16
  • [10] Efficacy and safety of high-dose esomeprazole and amoxicillin dual therapy versus bismuth-containing quadruple therapy for Helicobacter pylori infection: a multicenter, randomized controlled clinical trial
    Mei, Hao
    Guo, Yan
    Zhao, Jing-Tao
    Yang, Jun
    Sun, Wen-jing
    Zhang, De-kui
    He, Ping
    Shi, Gang
    Su, Na-yun
    Han, Ran
    Lan, Chun-Hui
    THERAPEUTIC ADVANCES IN GASTROENTEROLOGY, 2022, 15
12345